Advancing two new preclinical programs in Alzheimer’s and Age-Related Macular Degeneration Closed calendar year 2023 with cash position of US$9.5 million 164% revenue growth in the commercial BayMedica subsidiary VANCOUVER,… Read More
– Over 8,000 patients 12 years of age and older with severe sickle cell disease or transfusion-dependent beta thalassemia may be eligible for treatment – LONDON, EN – Vertex Pharmaceuticals… Read More
Funding to attract and advance Canadian clinical research in inflammatory bowel disease TORONTO, ON – Takeda Canada Inc. (Takeda) is pleased to announce its support of the Canadian Inflammatory Bowel Disease… Read More
VANCOUVER, BC – SaNOtize Research & Development Corp., a therapeutics technology company based in Vancouver, BC, announced the start of a Phase 2 safety and efficacy trial of its novel… Read More
KIRKLAND, QC – Pfizer Canada announced that Health Canada has granted a Notice of Compliance with conditions (NOC/c) to ELREXFIO (elranatamab solution for injection). ELREXFIO is indicated for the treatment… Read More
